REPORT ID 13852

EMEA (Europe, Middle East and Africa) Pneumococcal Vaccine Market Report 2019

Publish Date
2019
Pages
105
Format
Electronic (PDF)

In this report, the EMEA Pneumococcal Vaccine market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Pneumococcal Vaccine for these regions, from   2019 to 2025 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Pneumococcal Vaccine market competition by top manufacturers/players, with Pneumococcal Vaccine sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    MSD
    Sanofipasteur
    CDIB
    Pfizer
    GSK
    ...

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    PPSV 23
    PCV 7/13
    PCV 10

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Pneumococcal Vaccine for each application, including
    For Infants
    For Children (2-10)
    For Person (10-64)
    For The old (?65)

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Pneumococcal Vaccine Market  Report 2019
1 Pneumococcal Vaccine Overview
    1.1 Product Overview and Scope of Pneumococcal Vaccine
    1.2 Classification of Pneumococcal Vaccine
        1.2.1 EMEA Pneumococcal Vaccine Market Size (Sales) Comparison by Type ( 2014-2024)
        1.2.2 EMEA Pneumococcal Vaccine Market Size (Sales) Market Share by Type (Product Category)  in 2018
        1.2.3 PPSV 23
        1.2.4 PCV 7/13
        1.2.5 PCV 10
    1.3 EMEA Pneumococcal Vaccine Market by Application/End Users
        1.3.1 EMEA Pneumococcal Vaccine Sales (Volume) and Market Share Comparison by Application ( 2014-2024
        1.3.2 For Infants
        1.3.3 For Children (2-10)
        1.3.4 For Person (10-64)
        1.3.5 For The old (?65)
    1.4 EMEA Pneumococcal Vaccine Market by Region
        1.4.1 EMEA Pneumococcal Vaccine Market Size (Value) Comparison by Region ( 2014-2024)
        1.4.2 Europe Status and Prospect ( 2014-2024)
        1.4.3 Middle East Status and Prospect ( 2014-2024)
        1.4.4 Africa Status and Prospect ( 2014-2024)
    1.5 EMEA Market Size (Value and Volume) of Pneumococcal Vaccine ( 2014-2024)
        1.5.1 EMEA Pneumococcal Vaccine Sales and Growth Rate ( 2014-2024)
        1.5.2 EMEA Pneumococcal Vaccine Revenue and Growth Rate ( 2014-2024)

2 EMEA Pneumococcal Vaccine Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Pneumococcal Vaccine Market Competition by Players/Manufacturers
        2.1.1 EMEA Pneumococcal Vaccine Sales Volume and Market Share of Major Players ( 2014-2019)
        2.1.2 EMEA Pneumococcal Vaccine Revenue and Share by Players ( 2014-2019)
        2.1.3 EMEA Pneumococcal Vaccine Sale Price by Players ( 2014-2019)
    2.2 EMEA Pneumococcal Vaccine (Volume and Value) by Type/Product Category
        2.2.1 EMEA Pneumococcal Vaccine Sales and Market Share by Type ( 2014-2019)
        2.2.2 EMEA Pneumococcal Vaccine Revenue and Market Share by Type ( 2014-2019)
        2.2.3 EMEA Pneumococcal Vaccine Sale Price by Type ( 2014-2019)
    2.3 EMEA Pneumococcal Vaccine (Volume) by Application
    2.4 EMEA Pneumococcal Vaccine (Volume and Value) by Region
        2.4.1 EMEA Pneumococcal Vaccine Sales and Market Share by Region ( 2014-2019)
        2.4.2 EMEA Pneumococcal Vaccine Revenue and Market Share by Region ( 2014-2019)
        2.4.3 EMEA Pneumococcal Vaccine Sales Price by Region ( 2014-2019)

3 Europe Pneumococcal Vaccine (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Pneumococcal Vaccine Sales and Value ( 2014-2019)
        3.1.1 Europe Pneumococcal Vaccine Sales Volume and Growth Rate ( 2014-2019)
        3.1.2 Europe Pneumococcal Vaccine Revenue and Growth Rate ( 2014-2019)
    3.2 Europe Pneumococcal Vaccine Sales and Market Share by Type
    3.3 Europe Pneumococcal Vaccine Sales and Market Share by Application
    3.4 Europe Pneumococcal Vaccine Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Pneumococcal Vaccine Sales Volume by Countries ( 2014-2019)
        3.4.2 Europe Pneumococcal Vaccine Revenue by Countries ( 2014-2019)
        3.4.3 Germany Pneumococcal Vaccine Sales and Growth Rate ( 2014-2019)
        3.4.4 France Pneumococcal Vaccine Sales and Growth Rate ( 2014-2019)
        3.4.5 UK Pneumococcal Vaccine Sales and Growth Rate ( 2014-2019)
        3.4.6 Russia Pneumococcal Vaccine Sales and Growth Rate ( 2014-2019)
        3.4.7 Italy Pneumococcal Vaccine Sales and Growth Rate ( 2014-2019)
        3.4.8 Benelux Pneumococcal Vaccine Sales and Growth Rate ( 2014-2019)

4 Middle East Pneumococcal Vaccine (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Pneumococcal Vaccine Sales and Value ( 2014-2019)
        4.1.1 Middle East Pneumococcal Vaccine Sales Volume and Growth Rate ( 2014-2019)
        4.1.2 Middle East Pneumococcal Vaccine Revenue and Growth Rate ( 2014-2019)
    4.2 Middle East Pneumococcal Vaccine Sales and Market Share by Type
    4.3 Middle East Pneumococcal Vaccine Sales and Market Share by Application
    4.4 Middle East Pneumococcal Vaccine Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Pneumococcal Vaccine Sales Volume by Countries ( 2014-2019)
        4.4.2 Middle East Pneumococcal Vaccine Revenue by Countries ( 2014-2019)
        4.4.3 Saudi Arabia Pneumococcal Vaccine Sales and Growth Rate ( 2014-2019)
        4.4.4 Israel Pneumococcal Vaccine Sales and Growth Rate ( 2014-2019)
        4.4.5 UAE Pneumococcal Vaccine Sales and Growth Rate ( 2014-2019)
        4.4.6 Iran Pneumococcal Vaccine Sales and Growth Rate ( 2014-2019)

5 Africa Pneumococcal Vaccine (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Pneumococcal Vaccine Sales and Value ( 2014-2019)
        5.1.1 Africa Pneumococcal Vaccine Sales Volume and Growth Rate ( 2014-2019)
        5.1.2 Africa Pneumococcal Vaccine Revenue and Growth Rate ( 2014-2019)
    5.2 Africa Pneumococcal Vaccine Sales and Market Share by Type
    5.3 Africa Pneumococcal Vaccine Sales and Market Share by Application
    5.4 Africa Pneumococcal Vaccine Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Pneumococcal Vaccine Sales Volume by Countries ( 2014-2019)
        5.4.2 Africa Pneumococcal Vaccine Revenue by Countries ( 2014-2019)
        5.4.3 South Africa Pneumococcal Vaccine Sales and Growth Rate ( 2014-2019)
        5.4.4 Nigeria Pneumococcal Vaccine Sales and Growth Rate ( 2014-2019)
        5.4.5 Egypt Pneumococcal Vaccine Sales and Growth Rate ( 2014-2019)
        5.4.6 Algeria Pneumococcal Vaccine Sales and Growth Rate ( 2014-2019)

6 EMEA Pneumococcal Vaccine Manufacturers/Players Profiles and Sales Data
    6.1 MSD
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Pneumococcal Vaccine Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 MSD Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.1.4 Main Business/Business Overview
    6.2 Sanofipasteur
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Pneumococcal Vaccine Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Sanofipasteur Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.2.4 Main Business/Business Overview
    6.3 CDIB
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Pneumococcal Vaccine Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 CDIB Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.3.4 Main Business/Business Overview
    6.4 Pfizer
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Pneumococcal Vaccine Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Pfizer Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.4.4 Main Business/Business Overview
    6.5 GSK
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Pneumococcal Vaccine Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 GSK Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.5.4 Main Business/Business Overview
    ...

7 Pneumococcal Vaccine Manufacturing Cost Analysis
    7.1 Pneumococcal Vaccine Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Pneumococcal Vaccine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Pneumococcal Vaccine Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Pneumococcal Vaccine Major Manufacturers  in 2018
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Pneumococcal Vaccine Market Forecast ( 2019-2025)
    11.1 EMEA Pneumococcal Vaccine Sales, Revenue and Price Forecast ( 2019-2025)
        11.1.1 EMEA Pneumococcal Vaccine Sales and Growth Rate Forecast ( 2019-2025)
        11.1.2 EMEA Pneumococcal Vaccine Revenue and Growth Rate Forecast ( 2019-2025)
        11.1.3 EMEA Pneumococcal Vaccine Price and Trend Forecast ( 2019-2025)
    11.2 EMEA Pneumococcal Vaccine Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.3 Europe Pneumococcal Vaccine Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.4 Middle Eastt Pneumococcal Vaccine Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.5 Africa Pneumococcal Vaccine Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.6 EMEA Pneumococcal Vaccine Sales Forecast by Type ( 2019-2025)
    11.7 EMEA Pneumococcal Vaccine Sales Forecast by Application ( 2019-2025)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer